Scientific article
English

Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies

Contributors

Beghetti, Maurice

Published in

Heart, vol. 96, no. 12, p. 911-916

Publication date

2010

Abstract

In recent decades, the Fontan procedure and its variations have resulted in markedly improved outcomes of patients with single-ventricle physiology. These improvements are expected to increase greatly the number of surviving patients, particularly those surviving long into adulthood. However, there is still a progressive risk of attrition and failure of the Fontan circulation over time, the underlying pathophysiology of which is not fully understood. Current evidence suggests that alterations in the structure and function of the pulmonary vasculature may play a pivotal role. Recent evidence suggests that therapies approved for pulmonary arterial hypertension may provide benefits in this increasingly important patient population.

Keywords

  • Fontan Procedure/*adverse effects
  • Heart Defects, Congenital/surgery
  • Humans
  • Hypertension, Pulmonary/*etiology/physiopathology/*therapy
  • Protein-Losing Enteropathies/etiology/therapy
  • Pulmonary Circulation/*physiology
  • Survivors

Citation (ISO format)

BEGHETTI, Maurice. Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies. In: Heart, 2010, vol. 96, n° 12, p. 911–916. doi: 10.1136/hrt.2010.193912

Main files (1)

Article

Identifiers

Additional URL for this publication

http://heart.bmj.com/content/96/12/911.full.pdf

Journal ISSN

1355-6037
580views
0downloads

Technical informations

Creation

23/05/2012 08:44:11

First validation

23/05/2012 08:44:11

Update

14/03/2023 17:31:43

Status update

14/03/2023 17:31:43

Last indexation

29/10/2024 19:55:37
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated